https://www.selleckchem.com/pr....oducts/crenolanib-cp
4years after diagnosis. We observed no associations between randomized treatment to vitamin D and functional limitations (odds ratio [OR] 1.01, 95% confidence interval [CI] 0.52, 1.97) or physical disability (Rosow-Breslau scale OR 0.92, 95% CI 0.50, 1.67; Katz scale OR 1.03, 95% CI 0.31, 3.42). Those randomized to n-3 fatty acids had a non-significantly lower risk of functional limitations (OR 0.55, 95% CI 0.28, 1.09) and physical disability (Rosow-Breslau scale OR0.56, 95% CI 0.31, 1.02; Katz sclae OR0.32, 95% CI 0.50, 1.